Reaction Details Report a problem with these data
Target
Interleukin-17A
Ligand
BDBM419246
Substrate
n/a
Meas. Tech.
I L-17A Secretion
IC50
550±n/a nM
Citation
 Musicki, B; Bouix-Peter, C; Ouvry, G; Thoreau, E Benzenesulfonamide derivatives as inverse agonists of retinoid-related orphan receptor gamma (RORγ(T)) US Patent  US10457637 Publication Date 10/29/2019 
Target
Name:
Interleukin-17A
Synonyms:
CTLA8 | Cytotoxic T-lymphocyte-associated antigen 8 | IL-17 | IL17 | IL17A | IL17_HUMAN | il-17a
Type:
Enzyme Catalytic Domain
Mol. Mass.:
17511.44
Organism:
Homo sapiens (Human)
Description:
Q16552
Residue:
155
Sequence:
MTPGKTSLVSLLLLLSLEAIVKAGITIPRNPGCPNSEDKNFPRTVMVNLNIHNRNTNTNPKRSSDYYNRSTSPWNLHRNEDPERYPSVIWEAKCRHLGCINADGNVDYHMNSVPIQQEILVLRREPPHCPNSFRLEKILVSVGCTCVTPIVHHVA
  
Inhibitor
Name:
BDBM419246
Synonyms:
N-(4-ethylphenyl)-N- isobutyl-4-(((2- methoxypyridin-4- yl)methyl)amino)-3-(S- methylsulfonimidoyl) benzenesulfonamide | US10457637, Compound 127
Type:
Small organic molecule
Emp. Form.:
C26H34N4O4S2
Mol. Mass.:
530.703
SMILES:
CCc1ccc(cc1)N(CC(C)C)S(=O)(=O)c1ccc(NCc2ccnc(OC)c2)c(c1)S(C)(=N)=O
Structure:
Search PDB for entries with ligand similarity: